ENDRA Life Sciences Inc (NDRA) insider trading
Every open-market stock purchase and sale by ENDRA Life Sciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: UBS Group AG (10% owner), $2.1K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $4.78 on Oct 22, 2026.
Recent NDRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 2, 2026 | Richard Jacroux (CFO) | Bought (not open market) | — |
| Mar 2, 2026 | Alexander Y Tokman (CEO) | Bought (not open market) | — |
| Jan 21, 2026 | Lou Basenese (Insider) | Bought (not open market) | — |
| Jan 21, 2026 | Richard Jacroux (CFO) | Bought (not open market) | — |
| Jan 21, 2026 | Anthony Digiandomenico (Insider) | Bought (not open market) | — |
| Jan 21, 2026 | Michael Harsh (Insider) | Bought (not open market) | — |
| Jan 21, 2026 | Alexander Y Tokman (CEO) | Bought (not open market) | — |
Who's trading NDRA
- Richard Jacroux, CFO: other filings, last Mar 2, 2026
- Alexander Y Tokman, CEO: other filings, last Mar 2, 2026
- Lou Basenese, Insider: other filings, last Jan 21, 2026
- Anthony Digiandomenico, Insider: other filings, last Jan 21, 2026
- Michael Harsh, Insider: other filings, last Jan 21, 2026
Get free alerts when an insider at ENDRA Life Sciences Inc files a new trade →